144
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database

, , , , ORCID Icon & ORCID Icon
Pages 473-479 | Published online: 26 Aug 2020

References

  • Johnson NP, Hummelshoj L, World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552–1568. doi:10.1093/humrep/det050
  • Adamson GD, Kennedy S, Hummelshoj L. Creating solutions in endometriosis: global collaboration through the World Endometriosis Research Foundation. J Endometr. 2010;2(1):3–6. doi:10.1177/228402651000200102
  • Soliman AM, Coyne KS, Zaiser E, Castelli-Haley J, Fuldeore MJ. The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study. J Psychosom Obstet Gynaecol. 2017;38(4):238–248. doi:10.1080/0167482X.2017.1289512
  • Culley L, Law C, Hudson N, et al. The social and psychological impact of endometriosis on women’s lives: a critical narrative review. Hum Reprod Update. 2013;19(6):625–639. doi:10.1093/humupd/dmt027
  • Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women’s lives: a qualitative study. BMC Womens Health. 2014;14:123. doi:10.1186/1472-6874-14-123
  • Soliman AM, Surrey E, Bonafede M, Nelson JK, Castelli-Haley J. Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States. Adv Ther. 2018;35(3):408–423. doi:10.1007/s12325-018-0667-3
  • National Guidance Alliance (UK). Endometriosis: diagnosis and management. London: National Institute for Health and Care Excellence (UK); 2017. Available from: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0096947/. Accessed March 12, 2020.
  • Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116(1):223–236.
  • As-Sanie S, Black R, Giudice LC, et al. Assessing research gaps and unmet needs in endometriosis. Am J Obstet Gynecol. 2019;221(2):86–94. doi:10.1016/j.ajog.2019.02.033
  • Barra F, Grandi G, Tantari M, et al. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opin Biol Ther. 2019;19:343–360. doi:10.1080/14712598.2019.1581761
  • OrilissaTM [package insert]. North Chicago, IL: AbbVie Inc; 2019.
  • Taylor HS, Giudice LC, Lessey BA, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377(1):28–40. doi:10.1056/NEJMoa1700089
  • IBM Watson Health. Data brochure. IBM MarketScan research databases for life sciences researchers. 2019. Available from: https://www.ibm.com/downloads/cas/OWZWJ0QO. Accessed March 18, 2020.
  • Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017;108(1):125–136. doi:10.1016/j.fertnstert.2017.05.004
  • De Graaff AA, D’Hooghe TM, Dunselman GA, et al. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod. 2013;28(10):2677–2685. doi:10.1093/humrep/det284
  • Shakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111(6):1285–1292. doi:10.1097/AOG.0b013e3181758ec6
  • Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses-a U.S. epidemic. 2012. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm. Accessed March 20, 2020.
  • Centers for Disease Control and Prevention. Opioid overdose. 2020. Available from: https://www.cdc.gov/drugoverdose/epidemic/index.html. Accessed March 20, 2020.
  • Lamvu G, Soliman AM, Manthena SR, Gordon K, Knight J, Taylor HS. Patterns of prescription opioid use in women with endometriosis: evaluating prolonged use, daily dose, and concomitant use with benzodiazepines. Obstet Gynecol. 2019;133(6):1120–1130. doi:10.1097/AOG.0000000000003267
  • As-Sanie S, Soliman AM, Evans K, Erpelding N, Lanier R, Katz NP. Healthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: a retrospective claims database analysis. J Med Econ. 2020;23:371–377. doi:10.1080/13696998.2019.1707212
  • Fuldeore MJ, Soliman AM. Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women. Gynecol Obstet Invest. 2017;82(5):453–461. doi:10.1159/000452660